uBiome, an online health screening company, receives $83 million in Series C funding round
uBiome, based in San Francisco, started out offering a test of user’s gut health for the proper bacteria needed for healthy digestion but has since expanded to offer other health screenings for its users.
- uBiome will use the funds on expanding into drug discovery, moving its therapeutics unit to Cambridge, Massachusetts and announcing former Novartis CEO Joseph Jimenez to their board of directors.
- The Series C funding round was led by OS Fund and saw participation from 8VC, Y Combinator, Dentsu Ventures, and others. uBiome has raised a total of $105 million in funding.
- “This financing allows us to expand our product portfolio, increase our focus on patent assets and further raise our clinical profile, especially as we begin to focus on commercialization of drug discovery and development of our patent assets,” said founder Jessica Richman.